Anti-FCG2A/ FCGR2A/ CD32 monoclonal antibody

Anti-FCG2A/ FCGR2A/ CD32 antibody for FACS & in-vivo assay

Target products collectionGo to FCGR2A/FCGR2A products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-T22212-Ab-1/ GM-Tg-hg-T22212-Ab-2Anti-Human FCGR2A monoclonal antibodyHuman
GM-Tg-rg-T22212-Ab-1/ GM-Tg-rg-T22212-Ab-2Anti-Rat FCGR2A monoclonal antibodyRat
GM-Tg-mg-T22212-Ab-1/ GM-Tg-mg-T22212-Ab-2Anti-Mouse FCGR2A monoclonal antibodyMouse
GM-Tg-cynog-T22212-Ab-1/ GM-Tg-cynog-T22212-Ab-2Anti-Cynomolgus/ Rhesus macaque FCGR2A monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-T22212-Ab-1/ GM-Tg-felg-T22212-Ab-2Anti-Feline FCGR2A monoclonal antibodyFeline
GM-Tg-cang-T22212-Ab-1/ GM-Tg-cang-T22212-Ab-2Anti-Canine FCGR2A monoclonal antibodyCanine
GM-Tg-bovg-T22212-Ab-1/ GM-Tg-bovg-T22212-Ab-2Anti-Bovine FCGR2A monoclonal antibodyBovine
GM-Tg-equg-T22212-Ab-1/ GM-Tg-equg-T22212-Ab-2Anti-Equine FCGR2A monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-T22212-Ab-1/ GM-Tg-hg-T22212-Ab-2; GM-Tg-rg-T22212-Ab-1/ GM-Tg-rg-T22212-Ab-2;
GM-Tg-mg-T22212-Ab-1/ GM-Tg-mg-T22212-Ab-2; GM-Tg-cynog-T22212-Ab-1/ GM-Tg-cynog-T22212-Ab-2;
GM-Tg-felg-T22212-Ab-1/ GM-Tg-felg-T22212-Ab-2; GM-Tg-cang-T22212-Ab-1/ GM-Tg-cang-T22212-Ab-2;
GM-Tg-bovg-T22212-Ab-1/ GM-Tg-bovg-T22212-Ab-2; GM-Tg-equg-T22212-Ab-1/ GM-Tg-equg-T22212-Ab-2
Products NameAnti-FCGR2A monoclonal antibody
Formatmab
Target NameFCGR2A
Protein Sub-locationTransmembrane Protein
Category of antibodyFACS/Biofunctional Antibody, Therapeutics Target antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by using flow cytometry with antigen overexpressed cell line. The biofunction of antibodies are validated in cell-based assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-FCGR2A benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS,ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation Lyophilized from sterile PBS, PH 7.4
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenProducts DevelopingMulti-species FCG2A/ FCGR2A/ CD32 VLP (virus-like particle) (Products Developing)
    ORF Viral VectorpGMLP004748human FCGR2A Lentivirus plasmid
    ORF Viral VectorvGMLP004748human FCGR2A Lentivirus particle


    Target information

    Target IDGM-T22212
    Target NameFCGR2A
    Gene ID2212,719996
    Gene Symbol and SynonymsCD32,CD32A,CDw32,FCG2,FcgammaRIIa,FcGR,FCGR2,FCGR2A,FCGR2A1,FGCR,IGFR2
    Uniprot AccessionP12318
    Uniprot Entry NameFCG2A_HUMAN
    Protein Sub-locationTransmembrane Protein
    CategoryTherapeutics Target, Immuno-oncology Target
    DiseaseCancer
    Gene EnsemblENSG00000143226
    Target ClassificationCheckpoint-Immuno Oncology, Tumor-associated antigen (TAA)

    The target: FCGR2A, gene name: FCGR2A, also named as CD32, CD32A, CDw32, FCG2, FCGR21, FcGR, IGFR2, FCGR2A. This gene encodes one member of a family of immunoglobulin Fc receptor genes found on the surface of many immune response cells. The protein encoded by this gene is a cell surface receptor found on phagocytic cells such as macrophages and neutrophils, and is involved in the process of phagocytosis and clearing of immune complexes. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Oct 2008].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.